Why did MYX rise 7.3% on 11 Mar 2026?

Mayne Pharma hosted a business presentation discussing the U.S. launch and business model of DistributeRx, which was well-received by the market.

The only news on the event date is a business presentation about the U.S. launch of DistributeRx, suggesting investors responded positively to the strategic update. However, without details on specific metrics or outperformance, the cause is inferred rather than outright confirmed. The price move is significant but not extreme, warranting moderate confidence.

Written by a language model from the evidence below, and it can be wrong. Tell us and we will fix or remove it. General information only, not financial product advice.